This newly expanded white paper, authored by a renowned COA scientist, provides real-world examples of how electronic patient-reported outcome measures (PROMs) optimize data quality and reliability and improve the statistical power of trial data.
In this prerecorded webinar, industry experts discuss how EDC solutions address nuances in modern trial designs, such as flexible assessment settings, as well as assist modern working practices for study monitors and data managers.
This case study examines a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges faced by an emerging biopharmaceutical company.
Phase 1 clinical trials play an imperative role in terms of generating vital information about safety, tolerability, and dosage levels for new medications, yet they are often conducted using pen and paper for data capture and trial management. A unified platform is helping sponsors and CROs generate high-quality data, accelerate trials, and rapidly scale to Phase 2 and beyond.
